Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Robert H PressSarah L ShaferRenjian JiangZachary S BuchwaldMustafa AbugideiriSibo TianTiffany M MorganMadhusmita BeheraSoma SenguptaAlfredo D VoloschinJeffrey J OlsonShaakir HasanDeborah T BlumenthalWalter J CurranBree R EatonHui-Kuo G ShuJim ZhongPublished in: Cancer (2020)
The current data provide insight into the optimal timing of CRT in patients with glioblastoma and describe RPA class-specific outcomes. In general, short delays beyond 5 weeks did not negatively affect outcomes, whereas early initiation before 3 weeks may be detrimental.